Jonathan Block

Summit Therapeutics ( SMMT ) closed Monday down ~10% despite releasing positive late-stage data on Sunday on ivonescimab as a first-line treatment for non-small cell lung cancer.

wildpixel Hims & Hers Health ( HIMS ) has completed its acquisition of Eucalyptus, providing the telehealth company with access to markets in Australia, Canada, and Japan.

eternalcreative The European Commission has approved AbbVie's ( ABBV ) Aquipta (atogepant) as a treatment for migraine, with or without aura.

Douglas Rissing/iStock via Getty Images A biopharmaceutical company involved in developing drugs derived from cannabinoids, as well as

narvo vexar The US FDA has issued draft guidance intended to accelerate the development of gene and cell therapies.

Justin Sullivan/Getty Images News The US FDA has expanded the indication for Agilent Technology's ( A PD-L1 IHC 22C3 pharmDx test to aid in

IDEAYA Bioscience ( IDYA ) and Roche ( RHHBY ) have agreed to jointly evaluate a combination of the former's IDE892 with the latter's RG6505 for MTAP-deleted RAS-mutant pancreatic cancer.

Alexey_Fedoren On the heels of reporting fiscal 2026 Q4 results that beat on both lines, BTIG upgraded Medtronic ( MDT ) to buy from hold citing organic growth with an improving trajectory.

Just_Super Alnylam Pharmaceuticals ( ALNY ) has signed a deal potentially worth up to $2B with Inceptive Nucleics to use generative AI models to accelerate the development of RNAi therapeutics.

filo Veeva Systems ( VEEV ) is down ~4% in after-hours trading Wednesday despite reporting fiscal 2027 Q1 results that beat on both lines and raising full-year guidance.